Importantly, safe fat removal is not defined by a fixed limitit is determined by patient physiology, surgical strategy, and meticulous intraoperative management
Therefore, there are limited clinical trial data with semaglutide use in pregnant women. While evidence in humans is lacking, animal studies have suggested semaglutide can cause foetal abnormalities
References National Institutes of Health Office of Dietary Supplements MedlinePlus National Organization for Rare Disorders Mayo Clinic European Food Safety Authority This article is for general information only and is not a substitute for professional medical advice
Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer
When combined with insulin or sulfonylureas, dose adjustments of these medications may be necessary to reduce the risk of hypoglycaemia, and should only be made under healthcare professional supervision